Solar Winners & Losers: Suntech Sheds Gains

On Monday, Suntech Power ( STP) continued putting its stamp on the Chinese market when it announced a series of solar project deals with four local Chinese governments. The projects for the governments in Shaanxi, Shizuishan, Qinghai and Panzihua will total 1.8 gigawatts. Suntech, China's biggest solar concern, said the arrangements are still attracting investment and must meet a number of regulatory approvals.

"With ongoing investment in technology and innovation, Suntech is determined to continue to drive the cost to grid parity and encourage greater adoption of solar throughout China," Suntech CEO Dr. Zhengrong Shi said in a press release.

Though Suntech rose 4% on Monday, today found the company falling 3.4%, or 50 cents, at $14.42 in the afternoon.

Other solar shares having a rough go included First Solar ( FSLR) which was down 3.1%. SunPower ( SPWRA) and LDK Solar ( LDK) weren't doing much better, losing 3.7% and 2.4%, respectively, today.

Earlier Tuesday, LDK Solar said it acquired a controlling stake in Solar Green Technology, an Italian-based photovoltaic plant system integrator. The 70% stake will both expose LDK Solar to the Italian market, while helping SGT grow. No other financial details were revealed in the company's press release.

One bright spot on the day was Canadian Solar ( CSIQ), which saw its shares soaring 8.6%, or 87 cents, at $11.00.

Copyright 2009 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says